2 unknown, 1 completed, 1 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Wei Wang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety and Efficacy of NouvSoma001 in Ischemic Stroke extracellular vesicles derived from human induced neural stem cell for intravenous injection, a placebo of extracellular vesicles derived from human induced neural stem cell for intravenous injection - Ischemic Stroke | Phase 1 | Recruiting | Wei Wang | 69 | 2025-11-30 | 2026-01-21 |
| Intravenous Immunoglobulin for Acute Intracranial Hemorrhage Immunoglobulin Therapy, Standard management - Intracranial Hemorrhage, Hypertensive | Phase 2 | Unknown | Wei Wang | 60 | 2016-06-01 | 2016-05-25 |
| Efficacy Study of Acupuncture in the Prevention of Migraine Without Aura Verum acupuncture, Sham acupuncture, Usual care - Migraine Without Aura | Not applicable | Completed | Wei Wang | 150 | 2016-05-01 | 2019-09-09 |
| MRI,Gene And Cognitive Performance Study of Patients With Cerebral White Matter Lesions(WMLs) Cerebral White Matter Lesions | Unknown | Wei Wang | 200 | 2014-03-01 | 2015-12-14 |
Cerebral Hemorrhage (1) · Cognitive Dysfunction (1) · Intracranial Hemorrhage, Hypertensive (1) · Ischemic Stroke (1) · Migraine without Aura (1)
Immunization, Passive (1) · Immunoglobulins, Intravenous (1) · Injections, Intravenous (1)
China (4)
Chuan Qin, MD (1) · Daishi Tian, MD (1)